Aurobindo Pharma Ltd. — Regulatory Filings 2026

May 22, 2026

AUROBINDO

May 22, 2026

To Listing Department, NATIONAL STOCK EXCHANGE OF INDIA LIMITED Exchange Plaza, Bandra Kurla Complex, Bandra (E), MUMBAI -400 051 Company Code No. AUROPHARMA	To The Corporate Relations Department BSE LIMITED Phiroz Jeejeebhoy Towers, 25th floor, Dalal Street, MUMBAI -400 001 Company Code No. 524804

Dear Sir / Madam,

Sub: Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

This is to inform you that Agile Pharma BV, a wholly owned step down subsidiary of the Company, has incorporated a new wholly owned subsidiary in France by the name of Arrow Pharma Production SAS.

The disclosure pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and Part A of Schedule III of the aforesaid regulations, is attached as ‘Annexure A’.

This is for your information and records.

Yours faithfully,

For AUROBINDO PHARMA LIMITED

Digitally signed by ADI REDDY BADDIGAM

Date: 2026.05.22 12:15:37 +05'30'

B. Adi Reddy

Company Secretary

Enclosures: Annexure A

(CIN: L24239TG1986PLC015190)

AUROBINDO PHARMA LIMITED

www.aurobinodo.com

Corp. Off.: Galaxy, Floors: 22-24, Plot No.1, Survey No.83/1, Hyderabad Knowledge City, Raidurg Panmaktha, Ranga Reddy District, Hyderabad – 500 032, Telangana, India.

Tel: +91 40 6672 5000 / 6672 1200 Fax: +91 40 6707 4044.

Regd. off.: Plot No. 2, Maithrivihar, Ameerpet, Hyderabad - 500 038 Telangana, India Tel: +91 40 2373 6370 / 2374 7340 Fax: +91 40 2374 1080 / 2374 6833

Email: info@aurobinodo.com Website: www.aurobinodo.com

---

AUROBINDO

Annexure -A

Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

| i) Name of the entity, date & country of incorporation, etc.; | Arrow Pharma Production SAS
Creation of a new company in France on May 21, 2026. |
| --- | --- |
| ii) Name of holding company of the incorporated company and relation with the listed entity; | Agile Pharma BV, the Netherlands (“Agile”) is the holding company of Arrow Pharma Production SAS (the newly incorporated company), and Agile is a wholly owned step-down subsidiary of the Company and accordingly, Arrow Pharma Production SAS would also become a wholly owned stepdown subsidiary for the listed entity. |
| iii) Industry to which the entity being incorporated belongs; | Pharmaceuticals and engaged in manufacturing Generic Formulations. |
| iv) Brief background about the entity incorporated in terms of products / line of business; | The object of incorporation of this wholly owned subsidiary is to expand the manufacturing of generic formulations in France |
| v) Brief details of any governmental or regulatory approvals required for the incorporation; | No governmental or regulatory approvals required. |
| vi) Nature of consideration - whether cash consideration or share swap and details of the same; | 100% subscription to the share capital in cash.
Authorized capital is 100,000 EUR |
| vii) Cost of subscription / the price at which the shares are subscribed; | 100,000 EUR divided into 100,000 shares of value of 1 EUR each. |
| viii) Percentage of shareholding / control by the listed entity and / or number of shares allotted; | 100% shareholding and 100,000 shares of 1 EUR each. |

Digitally signed by ADI REDDY BADDIGAM
Date: 2026.05.22 12:16:01 +05'30'

(CIN : L24239TG1986PLC015190)

A UROBINDO PHARMA LIMITED

www. aurobindo . com

Corp. Off.: Galaxy, Floors: 22-24, Plot No.1, Survey No.83/1, Hyderabad Knowledge City, Raidurg Panmaktha, Ranga Reddy District, Hyderabad – 500 032, Telangana, India. Tel: +91 40 6672 5000 / 6672 1200 Fax: +91 40 6707 4044.

Regd. off.: Plot No. 2, Maithrivihar, Ameerpet, Hyderabad - 500 038 Telangana, India Tel: +91 40 2373 6370 / 2374 7340 Fax: +91 40 2374 1080 / 2374 6833

Email: info@aurobindo.com Website: www. aurobindo.com